In-Vitro Diagnostics, Intelligent Healthcare Systems, and Advanced Genetic Tools
Starting with pathfinder biomarkers to establish our clinical research, Genepika is rapidly advancing towards leveraging genetic engineering for precision diagnostics.
Our pathfinder diagnostics products will come to market in late 2025. Our goal at Genepika is to commercialize our research in rapid diagnostics and further our mission to enable affordable and accessible healthcare.
The long-term goal of Genepika is to push genetic engineering to its absolute limits for healthcare and far beyond.
Connect with us for partnership, research, or career opportunities - or for general inquiries.